Launch of newly developed diagnostic test kits for communicable diseases expected by end of 2022 to 2023

Published November 12, 2021, 3:14 PM

by Charissa Luci-Atienza 

The public can expect the launch of newly developed diagnostic test kits for other communicable diseases such as leptospirosis, tuberculosis, and human immunodeficiency virus (HIV) by the end of 2022 to 2023.

(Photo by JC Gellidon on Unsplash)

The Department of Science and Technology (DOST) said Friday, Nov. 12, bared that there were “five to eight ongoing projects” on the development of diagnostic test kits for communicable diseases.

“Sa kasalukuyan mayroon kaming lima hanggang walong projects na ongoing na at ineexpect natin na sunod sunod itong lalabas siguro mula towards the end of next year hanggang 2023 (We currently have five to eight projects that are ongoing and we expect that they will come out one after another starting maybe towards the end of next year until 2023),” DOST Undersecretary for Research and Development Dr. Rowena Cristina L. Guevara said during the Laging Handa briefing on Friday.

She noted that each year, the DOST-Philippine Council for Health Research and Development (PCHRD) allocates funds for projects on the development of the “timely” diagnostic test kits.

“May mga nakakahawang sakit tulad ng COVID-19, TB, HIV, at Neglected Tropical Diseases (NTDs) na binigyang prayoridad ng DOST sa paggawa ng mga nasabing diagnostic tests. Mahalaga na maisulong ito upang maagap na matugunan ang mga nasabing sakit sa pamamagitan ng maagang diagnosis (There are communicable diseases such as COVID-19, TB, HIV, and Neglected Tropical Diseases (NTDs) that are given priority by DOST in the development of diagnostic tests. It is important to promote this in order to promptly address these diseases through early diagnosis),” Guevara said.

She said after the Philippines developed the GenAmplify™ COVID-19 reverse transcription polymerase chain reaction (RT-PCR) detection kit and the Biotek-M Dengue Aqua Test Kit, the release of diagnostic test kits for leptospirosis, Chikungunya and Zika may be expected.

DOST-PCHRD Executive Director Jaime C. Montoya assured the public last week that the development of local diagnostic test kits continues to make these kits more affordable and accessible to Filipinos.